Skip to content

Malonylcarnitine (Serum)

Published: August 9, 2026Updated: August 16, 2026

This test measures the amount of malonylcarnitine, a type of carnitine linked to fatty acid metabolism, in your blood serum. It helps assess how well your body is breaking down fats and processing certain nutrients.

Quick summary

["Malonylcarnitine levels can indicate metabolic health and potential issues in fat metabolism."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
54461-9
Short code
Malonylcarn Amn-sCnc
Synonyms
Malonylcarn Amn-sCnc
Category
chemistry
Sample
fluid
Container
Sterile tube
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Specimen volume
2-5 mL
Stability
Room temperature: 2h, Refrigerated: 24h
Hemolysis max
300
TAT
4–24 hours
Order
routine

Why This Test Might Be Ordered

Your healthcare provider may recommend this test if you have symptoms like fatigue, muscle weakness, or unexplained weight changes. It could also be part of a broader evaluation for inherited metabolic disorders, liver disease, or conditions affecting fat metabolism, such as mitochondrial disorders or certain genetic conditions.

What to Expect Before the Test

No special preparation is usually needed, but you may be asked to fast for 8–12 hours before the test if instructed. Bring any medications you’re taking, as some may affect results. Avoid strenuous activity or excessive exercise the day before.

How the Test Is Performed

A blood sample is drawn from a vein in your arm by a healthcare professional. The blood is then sent to a lab for analysis using a specialized technique to measure malonylcarnitine levels.

What the Results Mean

Results are compared to a reference range specific to your lab. Elevated levels may suggest metabolic imbalances, while lower levels could indicate deficiencies or impaired fat metabolism. Your provider will interpret results in the context of your symptoms and medical history.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Clinical Significance

Frequently asked questions

What does malonylcarnitine measure?
Malonylcarnitine is a carnitine derivative that reflects how efficiently your body converts fats into energy. Abnormal levels may signal metabolic disorders, liver disease, or genetic conditions affecting fat metabolism, such as carnitine palmitoyltransferase deficiency.
Can diet affect malonylcarnitine levels?
Yes, dietary factors—such as high-fat or protein intake—can influence carnitine metabolism. Fasting or certain medications (e.g., some antibiotics or thyroid medications) may also impact results. Always follow your provider’s instructions for test preparation.
When should I follow up if my results are abnormal?
If your malonylcarnitine levels are outside the expected range, your provider will discuss next steps, which may include additional tests, dietary adjustments, or referral to a specialist (e.g., metabolic specialist or genetic counselor). Follow-up depends on your symptoms and overall health.
  1. 1
    MedlinePlus — Laboratory TestsSource
  2. 2
    Lab Tests OnlineSource
  3. 3
    Mayo Clinic — Tests & ProceduresSource

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy